Profound Medical
(TSX) PRN
Profound Medical Financials at a Glance
Market Cap
$297.97M
Revenue (TTM)
$18.40M
Net Income (TTM)
$45.71M
EPS (TTM)
$-1.97
P/E Ratio
-4.16
Dividend
$0.00
Beta (Volatility)
1.07 (Average)
Dividend
$0.00
Beta (Volatility)
1.07 (Average)
Price
$8.21
Volume
23,389
Open
$9.03
Price
$8.21
Volume
23,389
Open
$9.03
Previous Close
$8.21
Daily Range
$8.17 - $9.07
52-Week Range
$5.23 - $12.40
Dividend
$0.00
Beta (Volatility)
1.07 (Average)
Price
$8.21
Volume
23,389
Open
$9.03
Previous Close
$8.21
Daily Range
$8.17 - $9.07
52-Week Range
$5.23 - $12.40
PRN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Profound Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
162
CEO
Arun S. Menawat, PhD, EMBA
Website
www.profoundmedical.comHeadquarters
Mississauga, ON L4W 5K5, CA
PRN Financials
Key Financial Metrics (TTM)
Gross Margin
70%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-67%
Return on Capital
-24%
Return on Assets
-24%
Earnings Yield
-24.04%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$297.97M
Shares Outstanding
36.29M
Volume
23.39K
Short Interest
0.00%
Avg. Volume
19.58K
Financials (TTM)
Gross Profit
$15.92M
Operating Income
$57.64M
EBITDA
$56.86M
Operating Cash Flow
$53.39M
Capital Expenditure
$245.93K
Free Cash Flow
$53.63M
Cash & ST Invst.
$81.87M
Total Debt
$6.46M
Profound Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$8.33M
+124.9%
Gross Profit
$5.56M
+120.5%
Gross Margin
66.77%
N/A
Market Cap
$297.97M
N/A
Market Cap/Employee
$2.10M
N/A
Employees
142
N/A
Net Income
$11.40M
-113.7%
EBITDA
$10.12M
-16.6%
Quarterly Fundamentals
Net Cash
$75.41M
+51.4%
Accounts Receivable
$7.20M
+2.2%
Inventory
$11.29M
+94.7%
Long Term Debt
$6.17M
+97.2%
Short Term Debt
$504.97K
-74.7%
Return on Assets
-23.67%
N/A
Return on Invested Capital
-23.85%
N/A
Free Cash Flow
$9.39M
-66.4%
Operating Cash Flow
$9.14M
-62.1%